It is plausible that inquiring about individual values is appropriate and ultimately helpful to patients receiving treatments for advanced cancers. But, the values of these cancer patients upstream of end-of-life are not widely known [1] . Furthermore, no specific person-centered advance care planning (ACP) paradigm yet exists for standard use by the medical oncology community. With the development of a whole-patient-centered ACP initiative PersonCentered Oncologic Care and Choices (P-COCC), we therefore seek to address patient perspectives in addition to specific choices about disease-modifying and medically intensive treatments such as cardiopulmonary resuscitation. In this study, we report on the development and initial testing of the values questions that comprise the P-COCC paradigm, having hypothesized pre-study that these questions would be appropriate to patients with advanced cancer.
Background
It is plausible that inquiring about individual values is appropriate and ultimately helpful to patients receiving treatments for advanced cancers. But, the values of these cancer patients upstream of end-of-life are not widely known [1] . Furthermore, no specific person-centered advance care planning (ACP) paradigm yet exists for standard use by the medical oncology community. With the development of a whole-patient-centered ACP initiative PersonCentered Oncologic Care and Choices (P-COCC), we therefore seek to address patient perspectives in addition to specific choices about disease-modifying and medically intensive treatments such as cardiopulmonary resuscitation. In this study, we report on the development and initial testing of the values questions that comprise the P-COCC paradigm, having hypothesized pre-study that these questions would be appropriate to patients with advanced cancer.
Methods

Study design
The overall study was planned in two successive parts, Part 1 and Part 2; both of which were approved by the Memorial Sloan Kettering Cancer Center (MSKCC) Institutional Review Board. Part 1 involved cognitive interviewing of 25 patients, and those results are presented in this report. Part 2 was designed to serve as a proof-of-concept, small-scale, singleblind randomized trial to measure acceptability, and other quantitative and qualitative effects, of P-COCC. As of the time of this manuscript submission, 75 participants in Part 2 are in the process of being randomized to Usual Care, Video, or Video and Interview (the P-COCC intervention arm).
Our P-COCC model ( Figure 1 ) is a novel construct, proposing that each person with cancer is a unique, multifaceted being whose care is influenced by key internal person factors and external person factors. The P-COCC intervention itself is two-pronged: the introspective narrative targets the internal person factors and is generated from a semi-structured interview on questions being assessed in this study, resulting in a personal values narrative which is transcribed and reviewed with the patient, ultimately for their keeping. The goals-of-care video is a decision aid pertinent to the external person factors, and can also impact a patient's preferences for care.
Participants
Eligibility criteria included: advanced gastrointestinal (GI) cancer, English fluency, 18 years of age or older, a plan to be seen at least monthly at an MSKCC GI medical oncology clinic, and a physician-estimated patient life expectancy between 1 and 12 months. Exclusion criteria included psychiatric or cognitive disturbance which, in the physician's judgment, would preclude informed consent or adequate participation in the interventions.
Given that age (below or above 60 years) and performance status (high [Eastern Cooperative Oncology Group (ECOG) 0-1] or low [ECOG 2-3]) [2] might potentially influence illness experience and values, we aimed to recruit six patients in each of the four possible categories made up by these two variables (target sample size of 24 total participants). Six patients per group have been postulated [3] to be sufficient in reaching saturation in cognitive interviewing of homogeneous subjects about overarching themes.
Materials
Consented study participants were asked to assess the P-COCC questions for content, clarity, comfort, and tone. In total, the questions were assembled and grouped to address broad ACP themes of advanced cancer patients who regularly attend medical oncology clinics for visits with their oncologist and chemotherapy. The questions were also designed in order to be used in Part 2 of the study as a modified Dignity Therapy [4] program.
Of our ten questions, six were from a previously-honed [5] version of an ACP interview prototype, the Living Well Interview, to which we added additional interview questions: [1] one question about desired health care proxies, [2] two questions about our goals-of-care video, and [3] the Patient Dignity Question, which elicits what is essential for a health care team to know about a person [6] .
The goals-of-care video that subjects viewed has known benefits [7, 8] , is 6 minutes long, and depicts the components of three broad health care categories, life-prolonging care, limited care, and comfort care. Figure 2 shows where the video fit into the interview.
Testing and analysis
Study staff conducted brief (approximately 20 minutes) audio-recorded one-on-one cognitive interviews in person with study participants in a private, quiet clinic space.
The study principal investigator (A.S.E.) and a coinvestigator from the MSKCC Department of Psychiatry independently listened to and took notes on the audio records of subject responses. They then met with an additional coinvestigator (E.S.) to discuss and revise the prompts for further use in Part 2 of the study. Changes were made according to cognitive interviewing standards [9] regarding questionnaire creation, including revision, omission and/or addition of new questions depending on participant responses.
Results
From October 23, 2013 to August 15, 2014, 25 patients with advanced gastrointestinal cancers were recruited and interviewed to assess the appropriateness of the P-COCC interview questions. The final set of questions generated, after data analysis, is shown in Figure 2 .
The mean age of participants was 62 years, and 50% were female. Figure 3 illustrates the pool from which these 25 participants were drawn. The most common cancers represented in the final sample were pancreatic (50%) and colorectal (19%). Of the four planned groups of six participants each, only one participant was recruited into the group defined by being younger than 60 years old and with ECOG performance status ≥ 2 (this being an uncommon patient group in this usually chemotherapy-eligible adult GI medical oncology clinic). The other three groups had at least six participants each. Patients ultimately died within the predicted time interval from the time of consent (mean 9 months).
Ten participants (40%) indicated that some of the ten questions were uncomfortable to consider (median 3.5, range 1-6, no specific questions more than others), but that they were all nonetheless relevant and necessary for patients in their situation to be asked. Overall, to half the interview questions, participants suggested minor modifications, such as removing short segments of limited clarity, separating a question regarding concerns about illness and medical care into two questions, and keeping terminology consistent between that used in the video and in the questions about the video. There were no disagreements between members of the study team regarding these P-COCC question revisions.
Discussion
Through cognitive interviews with 25 patients with advanced GI cancers, we validated the appropriateness 
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A novel advance care planning paradigm for advanced cancer of questions about the values of people receiving treatment for these serious illnesses. These questions are part of our newly-created ACP paradigm P-COCC.
We adhered to standards of piloting behavioral intervention research [10] . Our study therefore serves as a methodologic building block towards the creation of an ACP program for patients being treated with chemotherapy for advanced GI cancers, which is a diverse and highly prevalent population in oncology. As an ACP program, P-COCC targets both the internal (person values) and external (care choices) patient realms; and, it strengthens the foundation laid by the previously-honed [5] version of an ACP interview prototype, the Living Well Interview.
Our study also has limitations: It was conducted at a single tertiary cancer center solely in patients with GI cancers; there was an underrepresentation of debilitated patients younger than 60 years old; and themes of pertinence to ACP in this population may have been missing.
The discomfort reported by several participants in this study reflects the delicate nature of having advanced cancer and discussing values regarding ACP in that context. Nonetheless, all these participants indicated that such questions were necessary and relevant. Additionally, approximately one third of patients who were eligible declined to participate in the study, which reflects known challenges in accruing patients with advanced cancer to behavioral research.
This initial (Part 1) testing has validated the ACP questions about patient values, which we believe are crucial for patients to reflect on and discuss with their healthcare teams, in order for the best care to be delivered to each person.
Prior presentations of this work
None.
Potentially Eligible Patients (N=248)
Completed Study Participation (N=25)
Agreed to participate (N=26)
Consented and completed baseline measures
Eligible for Study (N=88)
Declined participation (N=31)*** Felt too ill to participate (N=2)
Desired more time to consider consenting (N=29)
Cancer not metastatic & ECOG performance status <2 (N=65) 3 months from cancer diagnosis (N=31)* Oncologist's concern that study participation would cause patient psychological harm (N=17)
Other reasons for ineligibility** (N=47)
Patient died after consenting and before study interview (N=1) Figure 3 . Study Flow Diagram. ECOG; Eastern Cooperative Oncology Group. *Was one of the eligibility criteria for the study but due to slow accrual due to this criteria, it was removed through an IRB-approved protocol amendment. **Not English proficient (N=17), patient not expected to be followed monthly at MSKCC (N=13), oncologist-estimated patient life expectancy not within 1-12 months (N=13), no MSKCC pathology confirmation of patient's disease (N=2), ineligible based on results of SPMSQ cognitive testing (N=1) or deemed by oncologist to be too cognitively impaired for study measures (N=1). ***Did not want to discuss topic ("too soon" and/or "want to stay positive") (N=21), did not want to watch video (N=6), were not interested in participating in research (N=2), did not have time to complete intervention (N=1), felt participation would upset family members (N=1).
Key points
• No person-centered advance care planning (ACP) standard exists for use by the oncology community.
• We conducted cognitive interviewing with advanced cancer patients to validate questions to be used in future patient interviews that are part of testing of a novel ACP program.
• The ten questions address major biopsychosocial ACP themes for patients with advanced cancer. Two of the questions query impressions about a video decision aid pertaining to goals of care, which subjects also viewed.
• 40% of the 25 participants were uncomfortable responding to some of the questions but voiced that the questions were nonetheless all relevant and necessary for similar patients to be asked. Participants suggested minor wording modifications to half the questions.
• These questions about individual values are being studied in a randomized controlled trial of acceptability and other effects of our program, which addresses both these patient values, as well as specific medical choices.
